from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0768/aldA

LFCtreatmentdescriptionclass of inhibitor

-0.489

Amikacinug/mL Amikacintranslation

-0.417

Cap5-10ug/mL Capreomycintranslation

1.601

Rox10-50 ug/mL Roxithromycintranslation

0.738

SM2-5 ug/mL Streptomycintranslation

-0.642

Tet5-10 ug/mL Tetracyclinetranslation

0.177

Rif0.2-5ug/mL Rifampicintranscription

-0.191

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.919

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.259

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.039

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.942

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.520

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.546

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.423

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.256

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.169

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.966

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.777

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.182

Nigericin50 uM Nigericinrespiration

-0.311

TRC10-150 ug/mL Triclosanrespiration

1.948

TRZ10-25 ug/mL Thioridazinerespiration

0.665

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.915

menadione6-10 ug/mL Menadionerespiration

0.222

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.287

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.170

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.274

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.686

NRP_1Non-replicating persistence stage 1dosRassociated

-0.466

Amp0.2mg/mL AmpicillincellWall

-0.154

Cephalexin20-100 ug/mL CephalexincellWall

-0.213

Cerulenin0.32-5 ug/mL CerulenincellWall

0.329

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.174

EMB10-20 ug/mL EthambutolcellWall

-0.044

Eta12-40 ug/mL EthionamidecellWall

-0.298

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.906

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.910

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.602

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.846

BZA0.12 mg/mL BenzamidearomaticAmides

0.366

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.122

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.142

H2O24 mM hydrogen peroxideDNAdamaging

-0.733

Levo10 ug/mL LevofloxacinDNAdamaging

-0.112

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.206

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.266

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.145

UVUV-irradiationDNAdamaging

1.924

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.311

Antimycin12.5-50 ug/mL Antimycin A?

-1.550

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.054

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.831

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.078

PA8240.2-2 ug/mL PA-824?

-0.637

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.014

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.825

Verapamil50 uM Verapamil?

-1.549

mercaptoethanol2 mM 2-Mercaptoethanol?

0.369

methoxatin10-20 ug/mL Methoxatin?